EKEN, A. Et Al. 2018. S1P1 receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology. ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis , (Berlin, Germany), 762.

EKEN, A., YETKİN, M. F., VURAL, A., Okuş, F. Z., CANATAN, H., ALTUNTAŞ, H., ... MİRZA, M.(2018). S1P1 receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology . ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (pp.762). Berlin, Germany

EKEN, AHMET Et Al. "S1P1 receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology," ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Berlin, Germany, 2018

EKEN, AHMET Et Al. "S1P1 receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology." ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis , Berlin, Germany, pp.762, 2018

EKEN, A. Et Al. (2018) . "S1P1 receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology." ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis , Berlin, Germany, p.762.

@conferencepaper{conferencepaper, author={AHMET EKEN Et Al. }, title={S1P1 receptor antagonists Fingolimod and SEW2871 affect human group 1 and 3 innate lymphoid cell biology}, congress name={ECTRIMS 2018 – 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis}, city={Berlin}, country={Germany}, year={2018}, pages={762} }